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Obesity and increased body weight are most feared for their deleterious impact on cardiovascular health. Obesity may promote the development of premature coronary artery disease even in young individuals, 2 as well as cardiac remodelling with left ventricular hypertrophy and left atrial enlargement resulting in heart failure and atrial fibrillation. 3 One of the main still unanswered questions is what is the best anthropometric biomarker that summarizes the complexity of nutritional status and body fat composition. Do we have reliable means to identify body fat percentage and can we do it in an easy and cost-effective way? In this issue of the European Journal of Preventive Cardiology, bioelectrical impedance analysis was tested as a prognostic tool in a cohort of 6486 subjects enrolled in the Prevention of Renal and Vascular End-stage Disease (PREVEND) study. Bioelectrical impedance analysis gave the opportunity to measure the body fat percentage accurately with relevant clinical implications for diet counselling and lifestyle management, with stronger power to predict outcome than body mass index and waist circumference. The putative protective effect of obesity described as the 'obesity paradox' may be simply due to our inability to measure adiposity accurately.
Mobile health and patients' expectation
'Mobile' health (m-Health) is defined as mobile applications (apps) -medical and public health practice supported by mobile technologies -that are delivering health information, screening patients, monitoring physiological signs and providing direct care and patient education. A step forward in patient care is the use of mobile computing technologies and smartphone apps (e-Health) with the aim to further simplify patient-device interaction and enhance patient-centred care. 4 Patients' expectations, therefore, are of the utmost importance for the implementation of e-Health and m-Health. This topic has not been largely studied and now, just in time, comes a study: presented here is the first study assessing the patients' interests with regard to the feasibility of a direct interaction between their implanted device (such as implantable cardioverter-defibrillator, cardiac resynchronization therapy) via remote monitoring technology and m-Health (smartphone app) as well as their acceptance of this technology, and determining which specific items of information may be perceived as most important to be delivered. Gaining a better insight into the patient perspective in relation to m-Health is of utmost importance for its acceptance and implementation. And we should always remember that the purpose of remote monitoring is to facilitate, not to replace, patientphysician interaction. Interestingly, indicators related to heart failure status were considered less important despite clinical status being an important predictor of outcomes and quality of life. 5 The importance of the face to face interaction approach between patient and healthcare provider cannot be understated: it is wellknown that compliance and documented changes in positive lifestyle behaviours decrease during and after the unsupervised months following hospitalization. 6 Circulating PCSK9 and lipid lowering drug New approaches have been investigated in order to reduce low-density lipoprotein cholesterol (LDL-C) and cardiovascular risk, including implementation of new drugs belonging to the PCSK9 inhibitor class. 7 In the plasma the levels of PCSK9 (i.e. proprotein convertase subtilisin/kexin type 9, an enzyme encoded by the PCSK9 gene in humans on chromosome 1) have been shown to correlate positively with LDL-C levels but the data on this are not unequivocal. A detailed review focusing on PCSK9 metabolism and the control of PCSK expression is published in this issue of the journal.
The correlation between PCSK9 and LDL-C level has been shown to be less significant than expected.
The interplay between hypercholesterolaemia and the inflammatory burden is here discussed, and it is speculated that the clinical cardiovascular preventive activity of PCSK9 antagonists may possibly be affected by the poor efficacy of these agents on circulating inflammatory markers, for example, high-sensitivity C-reactive protein (hsCRP). 8 This lack of anti-inflammatory efficacy is detected in patients with familial hypercholesterolaemia when they are switched from lipoprotein apheresis to PCSK9 inhibitors. 9 In the large FOURIER trial it was shown that patients with elevated hsCRP levels (>3 mg/dl) showed the best preventive response to treatment: those with a lower baseline hsCRP had an absolute cardiovascular risk reduction of 1.8%, versus a reduction of 2.6% for those with the highest baseline levels. In this respect, in homozygous familial hypercholesterolemia, excluding those with null LDLR mutations, it has been recommended to prescribe maximal lipid-lowering therapy, including lipoprotein apheresis plus a PCSK9 inhibitor. 10 Night-time blood pressure and urine sodium and sodium-potassium ratio Hypertension, although a key cardiovascular risk factor, is still poorly controlled in clinical practice.
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In this issue, Kim et al. clearly show that night-time blood pressure is not only a stronger predictor of clinical outcomes than daytime blood pressure, but it is also much more strongly influenced by sodium sensitivity. Intriguingly, as sodium sensitivity and hypertension are often intertwined in clinical practice, it is tempting to speculate that the former rather than the latter may be responsible for adverse clinical outcomes: yet this hypothesis certainly requires more mechanistic study. The results of the present study suggest that high sodium or a high ratio of sodium to potassium intake may have a strong effect on nighttime blood pressure in older individuals. Thus, in older individuals, sodium intake restriction with enhancement of potassium intake may play a role in controlling blood pressure and result in the reduction of adverse cardiovascular events. Meanwhile, it makes sense to keep advising our patients with hypertension to avoid foods containing high levels of sodium. Innovative strategies, such as smartphone-based applications, may be effective tools to help people achieve this goal. 12 Cost-effectiveness and screening performance of electrocardiogram handheld machine
The study from Proietti and colleagues adds an important piece of evidence in support of cost-effectiveness of systematic population screening for atrial fibrillation. They used a Markov-model based modelling analysis in 1000 hypothetical individuals that matched a national atrial fibrillation screening programme of the general population in Belgium (20 to >90 years). 13 A nurse-led electrocardiogram (ECG) screening with a validated handheld ECG (one single 30-s recording) allowed identification of 1.1% new atrial fibrillation patients. Their model accounted for a screening procedure undertaken yearly for 40 consecutive years and simulated the natural dynamics of the cohort. Given a willingness to pay for a quality-adjusted life year of 4000, the screening programme was cost-effective not only for subjects 65 years and subjects 75 years, but also for the general population.
While the accuracy of measuring the exact heart rate may be low, depending on the application, 14 detection of an irregular heart rhythm compatible with atrial fibrillation seems possible, with high sensitivity and specificity (both >98%) in selected populations.
Mitochondrial DNA and cardiovascular diseases
Mitochondrial DNA (mtDNA) encodes for 22 transfer RNAs (tRNAs) and two ribosomal RNAs that regulate its transcription and replication and has been related to Mendelian disorders, such as some skeletal myopathies, and complex diseases such as diabetes. 15 Ionizing radiation is one of the exposures that can induce the appearance of somatic mutations or the progression of clonal mutated mtDNAs, either by increasing reactive oxidative species or by affecting the functionality of proteins repairing/maintaining mtDNA. Workers in a catheterization laboratory may offer a unique research model to address the health effects of low levels of ionizing radiation exposure on mtDNA.
Here is presented a study evaluating the relationship between long-term low-dose exposure to ionizing radiation and two mtDNA markers (mtDNA4977 deletion and mtDNA copy number) as potential mediators of the health effects of ionizing radiation, in catheterization laboratory workers (N ¼ 4147), using a crosssectional design that also included 74 non-exposed individuals.
The authors noted a direct association between ionizing radiation exposure and the number of mtDNA showing the 4977 deletion mutation, confirming their first hypothesis. mtDNA4977 deletion is a frequently studied variant, increases with aging, is a potential marker of mitochondrial dysfunction and has been related to several chronic cardiovascular diseases. 16 
Echocardiographic diagnosis of congenital coronary artery abnormalities
Coronary artery anomalies are a special issue in sportsrelated screening. Cardiac magnetic resonance imaging (MRI) screening can identify the specific type of coronary artery anomaly, including the origin and course, without the use of intravenous contrast agents or medications, and it has no ionizing radiation limitations. 17 Usually, MRI is used at present only as a secondary screening test for athletes who had a primary screening test with unclear results. 18 Here Gerling et al. claim to have achieved great accuracy and precision by using 'echocardiography screening' (although they more likely used 'clinical studies' performed by specialist physicians), but unfortunately no gold standard imaging, such as MRI or coronary contrast tomographic angiography, was used for comparison. True false-positive and, especially, false-negative results could not be fully evaluated by using such a protocol.
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